批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2015/09/10 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/04/26 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2003/04/18 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/09/04 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/06/10 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/06/10 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/02/04 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/02/11 |
SUPPL-7(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
1997/03/11 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/09/27 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/04/18 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
;Orphan
|
|
|
1995/11/09 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1995/11/09 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1995/11/09 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1994/03/22 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
PRIORITY
;Orphan
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:PILOCARPINE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020237 |
001 |
NDA |
SALAGEN |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
Yes |
No |
AB |
1994/03/22
|
CONCORDIA |
076746 |
001 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
No |
No |
AB |
2004/11/16
|
PADAGIS US |
076963 |
001 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
No |
No |
AB |
2004/12/22
|
INNOGENIX |
077220 |
001 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
No |
No |
AB |
2005/10/14
|
LANNETT CO INC |
077248 |
001 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
No |
No |
AB |
2006/03/31
|
IMPAX LABS |
212377 |
001 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
5MG |
Prescription |
No |
No |
AB |
2019/08/13
|
AUROBINDO PHARMA LTD |
活性成分:PILOCARPINE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:7.5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020237 |
002 |
NDA |
SALAGEN |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
7.5MG |
Prescription |
Yes |
Yes |
AB |
2003/04/18
|
CONCORDIA |
077248 |
002 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
7.5MG |
Prescription |
No |
No |
AB |
2006/03/31
|
IMPAX LABS |
076963 |
002 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
7.5MG |
Prescription |
No |
No |
AB |
2007/02/27
|
INNOGENIX |
077220 |
002 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
7.5MG |
Prescription |
No |
No |
AB |
2009/05/06
|
LANNETT CO INC |
212377 |
002 |
ANDA |
PILOCARPINE HYDROCHLORIDE |
PILOCARPINE HYDROCHLORIDE |
TABLET;ORAL |
7.5MG |
Prescription |
No |
No |
AB |
2019/08/13
|
AUROBINDO PHARMA LTD |